Literature DB >> 15250891

Psychiatric morbidity in psoriasis: a review.

Paul A J Russo1, Ralf Ilchef, Alan J Cooper.   

Abstract

Psoriasis is a common condition, affecting 1.5-2% of the population of industrialized countries. It is important for clinicians to be aware that psoriasis can have a substantial emotional impact on an individual, which is not necessarily related to the extent of skin disease. This review examines current literature addressing the psychological and emotional aspects of psoriasis. A literature search of the MEDLINE (1966-2002) and PsycINFO (1984-2002) computer databases and bibliographies was carried out. Papers selected for the review included English language reviews and all original research relevant to the topic, in the form of randomized controlled trials, cohort studies, case-control studies, cross-over and uncontrolled clinical trials, patient surveys, quality-of-life studies, case series and case reports. Despite significant shortcomings, the available prevalence studies showed uniformly high rates of psychopathology among psoriasis sufferers. The few intervention studies available are summarized and critically discussed. Psoriasis is associated with a variety of psychological problems, including poor self esteem, sexual dysfunction, anxiety, depression and suicidal ideation. The clinical severity of the psoriasis may not reflect the degree of emotional impact of the disease. A number of psychological interventions have shown promise in recent trials. It is important that clinicians consider the psychosocial aspects of this illness.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15250891     DOI: 10.1111/j.1440-0960.2004.00078.x

Source DB:  PubMed          Journal:  Australas J Dermatol        ISSN: 0004-8380            Impact factor:   2.875


  48 in total

Review 1.  Diagnosis and management of psoriasis.

Authors:  Whan B Kim; Dana Jerome; Jensen Yeung
Journal:  Can Fam Physician       Date:  2017-04       Impact factor: 3.275

2.  Emotion Regulation in Patients with Psoriasis: Correlates of Disability, Clinical Dimensions, and Psychopathology Symptoms.

Authors:  Vera Almeida; Sofia Taveira; Maribel Teixeira; Isabel Almeida; José Rocha; Ana Teixeira
Journal:  Int J Behav Med       Date:  2017-08

3.  High Prevalence of Sexual Dysfunction in a Vulvovaginal Specialty Clinic.

Authors:  Dina Gordon; Carolyn Gardella; David Eschenbach; Caroline M Mitchell
Journal:  J Low Genit Tract Dis       Date:  2016-01       Impact factor: 1.925

4.  Health-related quality of life of pediatric patients with moderate to severe plaque psoriasis: comparisons to four common chronic diseases.

Authors:  James W Varni; Denise R Globe; Shravanthi R Gandra; David J Harrison; Michele Hooper; Scott Baumgartner
Journal:  Eur J Pediatr       Date:  2011-09-30       Impact factor: 3.183

5.  [Depression and anxiety disorders among psoriasis patients: protective and exacerbating factors].

Authors:  K Bangemann; W Schulz; J Wohlleben; A Weyergraf; I Snitjer; T Werfel; G Schmid-Ott; D Böhm
Journal:  Hautarzt       Date:  2014-12       Impact factor: 0.751

Review 6.  Ustekinumab: a review of its use in the management of moderate to severe plaque psoriasis.

Authors:  Jamie D Croxtall
Journal:  Drugs       Date:  2011-09-10       Impact factor: 9.546

Review 7.  Psoriasis and Associated Psychiatric Disorders: A Systematic Review on Etiopathogenesis and Clinical Correlation.

Authors:  Bárbara Isabel Roque Cunha Ferreira; José Luís Pio Da Costa Abreu; José Pedro Gaspar Dos Reis; Américo Manuel Da Costa Figueiredo
Journal:  J Clin Aesthet Dermatol       Date:  2016-06-01

Review 8.  Psoriasis and vascular disease-risk factors and outcomes: a systematic review of the literature.

Authors:  Rita V Patel; Michael L Shelling; Srdjan Prodanovich; Daniel G Federman; Robert S Kirsner
Journal:  J Gen Intern Med       Date:  2011-04-07       Impact factor: 5.128

9.  Disease Severity, Quality of Life, and Psychiatric Morbidity in Patients With Psoriasis With Reference to Sociodemographic, Lifestyle, and Clinical Variables: A Prospective, Cross-Sectional Study From Lahore, Pakistan.

Authors:  Abdul Rahman Khawaja; Syed Muhammad Azam Bokhari; Rasheed Tariq; Shahzad Atif; Hanif Muhammad; Qadeer Faisal; Mohammad Jafferany
Journal:  Prim Care Companion CNS Disord       Date:  2015-06-25

10.  Interleukin-1 regulates keratinocyte expression of T cell targeting chemokines through interleukin-1 receptor associated kinase-1 (IRAK1) dependent and independent pathways.

Authors:  Julio C Sanmiguel; Florina Olaru; Jieliang Li; Elisabeth Mohr; Liselotte E Jensen
Journal:  Cell Signal       Date:  2009-01-07       Impact factor: 4.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.